Shenzhen Bohai Gene Biotechnology Co., Ltd. is the world's leading three-generation single-molecule sequencing instrument R & D and manufacturing enterprise, the company's single-molecule sequencing system GenoCare is mainly for clinical applications. Recently, the universal sequencing kit independently developed by Bohai Gene successfully completed the first-class medical device registration and passed the audit, becoming the world's first three-generation single-molecule sequencing system kit registered by China's medical device registration, becoming the future clinical application market of Bohai Gene. Good start.
The approved reagent kit is a general sequencing kit, a set of universal sequencing kits for single-molecule level sequencing. Based on the template strand, it provides the special requirements needed for sequencing. Extend fluorescent bases, enzyme systems, and various reaction buffers.
The sequencing kit is used in conjunction with the clinical application kits independently developed by Bohai Gene containing different sequencing target gene chips, and the corresponding gene sequencing research work is carried out on the GenoCare single molecule sequencing system independently developed by Bohai Gene .
Bohai Gene CEO He Jiankui and GenoCare Sequencer
In 2014, Bohai Gene launched the research and development of the third-generation single-molecule sequencing system. So far, it has achieved a lot of research and development results, and won the title of national high-tech enterprise last year. It is reported that the prototype of GenoCare will be officially released this year.
Limbs Rehabilitation Device,Rehabilitation Instrument,Rehabilitation Training Bed,Electric Rehabilitation Bed
Puyang Degren Medical Equipment Co., Ltd. , https://www.degrenyuwei.com